Report Detail
Global and United States Intranasal Drug Delivery System Market Report & Forecast 2022-2028
- RnM4424730 |
- 22 April, 2022 |
- Global |
- 103 Pages |
- QYResearch |
- Medical Devices & Consumables
Summary:
Market Analysis and Insights: Global and United States Intranasal Drug Delivery System Market
This report focuses on global and United States Intranasal Drug Delivery System market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Intranasal Drug Delivery System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Nasal Drops accounting for % of the Intranasal Drug Delivery System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Intranasal Drug Delivery System market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Intranasal Drug Delivery System Scope and Market Size
Intranasal Drug Delivery System market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Intranasal Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Intranasal Drug Delivery System market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Intranasal Drug Delivery System market is segmented into
Nasal Drops
Nasal Sprays
Nasal Gels
Nasal Suspensions and Emulsion
Nasal Powders
Segment by Application, the Intranasal Drug Delivery System market is segmented into
Hospital
Clinic
Home Care
Others
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Intranasal Drug Delivery System Market Share Analysis
Intranasal Drug Delivery System market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Intranasal Drug Delivery System business, the date to enter into the Intranasal Drug Delivery System market, Intranasal Drug Delivery System product introduction, recent developments, etc.
The major vendors covered:
Aptar Pharma
Nemera
Teleflex
Mystic Pharmaceuticals
Zeteo Medical
Johnson & Johnson
GlaxoSmithKline Plc
Aegis Therapeutics LLC
H&T Presspart Manufacturing Ltd.
AstraZeneca Plc
Becton
BD
Novartis AG
Vectura Group Plc
Table of Contents
1 Study Coverage
- 1.1 Intranasal Drug Delivery System Product Introduction
- 1.2 Global Intranasal Drug Delivery System Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Intranasal Drug Delivery System Sales in US$ Million for the Year 2017-2028
- 1.2.2 Global Intranasal Drug Delivery System Sales in Volume for the Year 2017-2028
- 1.3 United States Intranasal Drug Delivery System Outlook 2017 VS 2022 VS 2028
- 1.3.1 United States Intranasal Drug Delivery System Sales in US$ Million for the Year 2017-2028
- 1.3.2 United States Intranasal Drug Delivery System Sales in Volume for the Year 2017-2028
- 1.4 Intranasal Drug Delivery System Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4.1 The Market Share of United States Intranasal Drug Delivery System in Global, 2017 VS 2022 VS 2028
- 1.4.2 The Growth Rate of Intranasal Drug Delivery System Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.5 Intranasal Drug Delivery System Market Dynamics
- 1.5.1 Intranasal Drug Delivery System Industry Trends
- 1.5.2 Intranasal Drug Delivery System Market Drivers
- 1.5.3 Intranasal Drug Delivery System Market Challenges
- 1.5.4 Intranasal Drug Delivery System Market Restraints
- 1.6 Study Objectives
- 1.7 Years Considered
2 Market by Type
- 2.1 Intranasal Drug Delivery System Market Segment by Type
- 2.1.1 Nasal Drops
- 2.1.2 Nasal Sprays
- 2.1.3 Nasal Gels
- 2.1.4 Nasal Suspensions and Emulsion
- 2.1.5 Nasal Powders
- 2.2 Global Intranasal Drug Delivery System Market Size by Type
- 2.2.1 Global Intranasal Drug Delivery System Sales in Value, by Type (2017, 2022 & 2028)
- 2.2.2 Global Intranasal Drug Delivery System Sales in Volume, by Type (2017, 2022 & 2028)
- 2.2.3 Global Intranasal Drug Delivery System Average Selling Price (ASP) by Type (2017, 2022 & 2028)
- 2.3 United States Intranasal Drug Delivery System Market Size by Type
- 2.3.1 United States Intranasal Drug Delivery System Sales in Value, by Type (2017, 2022 & 2028)
- 2.3.2 United States Intranasal Drug Delivery System Sales in Volume, by Type (2017, 2022 & 2028)
- 2.3.3 United States Intranasal Drug Delivery System Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
- 3.1 Intranasal Drug Delivery System Market Segment by Application
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.1.3 Home Care
- 3.1.4 Others
- 3.2 Global Intranasal Drug Delivery System Market Size by Application
- 3.2.1 Global Intranasal Drug Delivery System Sales in Value, by Application (2017, 2022 & 2028)
- 3.2.2 Global Intranasal Drug Delivery System Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 Global Intranasal Drug Delivery System Average Selling Price (ASP) by Application (2017, 2022 & 2028)
- 3.3 United States Intranasal Drug Delivery System Market Size by Application
- 3.3.1 United States Intranasal Drug Delivery System Sales in Value, by Application (2017, 2022 & 2028)
- 3.3.2 United States Intranasal Drug Delivery System Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 United States Intranasal Drug Delivery System Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Intranasal Drug Delivery System Competitor Landscape by Company
- 4.1 Global Intranasal Drug Delivery System Market Size by Company
- 4.1.1 Top Global Intranasal Drug Delivery System Manufacturers Ranked by Revenue (2021)
- 4.1.2 Global Intranasal Drug Delivery System Revenue by Manufacturer (2017-2022)
- 4.1.3 Global Intranasal Drug Delivery System Sales by Manufacturer (2017-2022)
- 4.1.4 Global Intranasal Drug Delivery System Price by Manufacturer (2017-2022)
- 4.2 Global Intranasal Drug Delivery System Concentration Ratio (CR)
- 4.2.1 Intranasal Drug Delivery System Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Intranasal Drug Delivery System in 2021
- 4.2.3 Global Intranasal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Intranasal Drug Delivery System Manufacturing Base Distribution, Product Type
- 4.3.1 Global Intranasal Drug Delivery System Manufacturers, Headquarters and Distribution of Producing Region
- 4.3.2 Manufacturers Intranasal Drug Delivery System Product Type
- 4.3.3 Date of International Manufacturers Enter into Intranasal Drug Delivery System Market
- 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
- 4.5 United States Intranasal Drug Delivery System Market Size by Company
- 4.5.1 Top Intranasal Drug Delivery System Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Intranasal Drug Delivery System Revenue by Players (2020, 2021 & 2022)
- 4.5.3 United States Intranasal Drug Delivery System Sales by Players (2020, 2021 & 2022)
5 Global Intranasal Drug Delivery System Market Size by Region
- 5.1 Global Intranasal Drug Delivery System Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Intranasal Drug Delivery System Market Size in Volume by Region (2017-2028)
- 5.2.1 Global Intranasal Drug Delivery System Sales in Volume by Region: 2017-2022
- 5.2.2 Global Intranasal Drug Delivery System Sales in Volume Forecast by Region (2023-2028)
- 5.3 Global Intranasal Drug Delivery System Market Size in Value by Region (2017-2028)
- 5.3.1 Global Intranasal Drug Delivery System Sales in Value by Region: 2017-2022
- 5.3.2 Global Intranasal Drug Delivery System Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
- 6.1.2 North America Intranasal Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Intranasal Drug Delivery System Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
- 6.3.2 Europe Intranasal Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Intranasal Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Intranasal Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 Aptar Pharma
- 7.1.1 Aptar Pharma Corporation Information
- 7.1.2 Aptar Pharma Description and Business Overview
- 7.1.3 Aptar Pharma Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.1.4 Aptar Pharma Intranasal Drug Delivery System Products Offered
- 7.1.5 Aptar Pharma Recent Development
- 7.2 Nemera
- 7.2.1 Nemera Corporation Information
- 7.2.2 Nemera Description and Business Overview
- 7.2.3 Nemera Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.2.4 Nemera Intranasal Drug Delivery System Products Offered
- 7.2.5 Nemera Recent Development
- 7.3 Teleflex
- 7.3.1 Teleflex Corporation Information
- 7.3.2 Teleflex Description and Business Overview
- 7.3.3 Teleflex Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.3.4 Teleflex Intranasal Drug Delivery System Products Offered
- 7.3.5 Teleflex Recent Development
- 7.4 Mystic Pharmaceuticals
- 7.4.1 Mystic Pharmaceuticals Corporation Information
- 7.4.2 Mystic Pharmaceuticals Description and Business Overview
- 7.4.3 Mystic Pharmaceuticals Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.4.4 Mystic Pharmaceuticals Intranasal Drug Delivery System Products Offered
- 7.4.5 Mystic Pharmaceuticals Recent Development
- 7.5 Zeteo Medical
- 7.5.1 Zeteo Medical Corporation Information
- 7.5.2 Zeteo Medical Description and Business Overview
- 7.5.3 Zeteo Medical Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.5.4 Zeteo Medical Intranasal Drug Delivery System Products Offered
- 7.5.5 Zeteo Medical Recent Development
- 7.6 Johnson & Johnson
- 7.6.1 Johnson & Johnson Corporation Information
- 7.6.2 Johnson & Johnson Description and Business Overview
- 7.6.3 Johnson & Johnson Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.6.4 Johnson & Johnson Intranasal Drug Delivery System Products Offered
- 7.6.5 Johnson & Johnson Recent Development
- 7.7 GlaxoSmithKline Plc
- 7.7.1 GlaxoSmithKline Plc Corporation Information
- 7.7.2 GlaxoSmithKline Plc Description and Business Overview
- 7.7.3 GlaxoSmithKline Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.7.4 GlaxoSmithKline Plc Intranasal Drug Delivery System Products Offered
- 7.7.5 GlaxoSmithKline Plc Recent Development
- 7.8 Aegis Therapeutics LLC
- 7.8.1 Aegis Therapeutics LLC Corporation Information
- 7.8.2 Aegis Therapeutics LLC Description and Business Overview
- 7.8.3 Aegis Therapeutics LLC Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.8.4 Aegis Therapeutics LLC Intranasal Drug Delivery System Products Offered
- 7.8.5 Aegis Therapeutics LLC Recent Development
- 7.9 H&T Presspart Manufacturing Ltd.
- 7.9.1 H&T Presspart Manufacturing Ltd. Corporation Information
- 7.9.2 H&T Presspart Manufacturing Ltd. Description and Business Overview
- 7.9.3 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.9.4 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Products Offered
- 7.9.5 H&T Presspart Manufacturing Ltd. Recent Development
- 7.10 AstraZeneca Plc
- 7.10.1 AstraZeneca Plc Corporation Information
- 7.10.2 AstraZeneca Plc Description and Business Overview
- 7.10.3 AstraZeneca Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.10.4 AstraZeneca Plc Intranasal Drug Delivery System Products Offered
- 7.10.5 AstraZeneca Plc Recent Development
- 7.11 Becton
- 7.11.1 Becton Corporation Information
- 7.11.2 Becton Description and Business Overview
- 7.11.3 Becton Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.11.4 Becton Intranasal Drug Delivery System Products Offered
- 7.11.5 Becton Recent Development
- 7.12 BD
- 7.12.1 BD Corporation Information
- 7.12.2 BD Description and Business Overview
- 7.12.3 BD Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.12.4 BD Products Offered
- 7.12.5 BD Recent Development
- 7.13 Novartis AG
- 7.13.1 Novartis AG Corporation Information
- 7.13.2 Novartis AG Description and Business Overview
- 7.13.3 Novartis AG Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.13.4 Novartis AG Products Offered
- 7.13.5 Novartis AG Recent Development
- 7.14 Vectura Group Plc
- 7.14.1 Vectura Group Plc Corporation Information
- 7.14.2 Vectura Group Plc Description and Business Overview
- 7.14.3 Vectura Group Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
- 7.14.4 Vectura Group Plc Products Offered
- 7.14.5 Vectura Group Plc Recent Development
8 Industry Chain and Sales Channels Analysis
- 8.1 Intranasal Drug Delivery System Industry Chain Analysis
- 8.2 Intranasal Drug Delivery System Key Raw Materials
- 8.2.1 Key Raw Materials
- 8.2.2 Intranasal Drug Delivery System Distributors
- 8.3 Intranasal Drug Delivery System Production Mode & Process
- 8.4 Intranasal Drug Delivery System Sales and Marketing
- 8.4.1 Intranasal Drug Delivery System Sales Channels
- 8.4.2 Intranasal Drug Delivery System Distributors
- 8.5 Intranasal Drug Delivery System Customers
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.2 Data Source
- 10.2 Author Details
Summary:
Get latest Market Research Reports on Intranasal Drug Delivery System. Industry analysis & Market Report on Intranasal Drug Delivery System is a syndicated market report, published as Global and United States Intranasal Drug Delivery System Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Intranasal Drug Delivery System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
